606143-52-6 Selumetinib AKSci X2640
 
 
Loading Please Wait...
  X2640    AKSci Reference Standard
Selumetinib
, 98% (HPLC), powder
 
AZD6244




IDENTITY
CAS Number:606143-52-6
MDL Number:MFCD11977472
MF:C17H15BrClFN4O3
MW:457.69
SPECIFICATIONS & PROPERTIES
Purity:98% (HPLC), powder
Spectra:NMR, LCMS, FT-IR, HPLC
Physical Form:White powder
Melting Point:>219°C
Density:1.692
Refractive Index:1.672
Long-Term Storage:Store long-term at -20°C

BIOLOGICAL INFO
Application(s):Inhibitor of MEK1

REVIEW

 Selumetinib (AZD6244) is a second-generation, orally available, potent and selective ATP non-competitive inhibitor of MEK 1/2. In direct assays, AZD6244 selectively inhibits purified active MEK1 and MEK2 with an IC50 of 14 nM, and AZD6244 has reported IC50 values of <100nm for MEK1 in ELISA assays and in bindings assays against recombinant domains of MEK2, Kd values were 53nM for AZD6244. AZD6244 demonstrated very effective anti-proliferation effects against several different cell lines with IC50 values ranging from a low of 3nM to < 1 µM depending upon the cell system used, and the compound inhibits basal and growth factor-stimulated phosphorylation of ERK1/ 2 with IC50 concentrations < 40 nM. AZD6244 has demonstrated potent dose-dependent antitumor activity against a panel of mouse xenograft models of colorectal, pancreatic, liver, skin, and lung cancer, and inhibition of tumor growth was found to correlate with the reduction of phospho-ERK1/2 levels in tumors.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


Current as of July 12, 2020

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES

 APIs and Bioactives > Protein Kinase Inhibitors


PubChem